Crescent Biopharma CBIO
NASDAQ CBIO
$14.66 -0.10 (-0.68%)
As of: Sep 30, 2026 · 3:55 PM EDT

Crescent Biopharma (CBIO) Other financing activities (2025)

Updated

Crescent Biopharma (CBIO) posted Other financing activities of $175,000 for Q2 2025.

Analysis

Crescent Biopharma (CBIO) Other financing activities (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Crescent Biopharma 409.68 Mn -297.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 175,000.00
Mar 31, 2025 2,000.00
API Access

Crescent Biopharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CBIO&period=max&api_key=YOUR_API_KEY